Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
SHINADA, Masahiro
42  Ergebnisse:
OpenAccess-Volltexte X
?
1

Podoplanin promotes cell proliferation, survival, and migra..:

SHINADA, Masahiro ; KATO, Daiki ; TSUBOI, Masaya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600541/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Expression of podoplanin in various types of feline tumor t..:

KAMOTO, Satoshi ; SHINADA, Masahiro ; KATO, Daiki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636872/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
3

PDPN Is Expressed in Various Types of Canine Tumors and Its..:

Shinada, Masahiro ; Kato, Daiki ; Kamoto, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290317/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
4

Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal..:

Kamoto, Satoshi ; Shinada, Masahiro ; Kato, Daiki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700559/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
5

Overexpression of human epidermal growth factor receptor 2 ..:

YOSHIMOTO, Sho ; KATO, Daiki ; KAMOTO, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324825/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
6

Author Correction: Aberrant expression of the COX2/PGE(2) a..:

Yoshitake, Ryohei ; Saeki, Kohei ; Eto, Shotaro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595033/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
7

Immunohistochemical evaluation of HER2 expression in canine..:

Yoshimoto, Sho ; Kato, Daiki ; Kamoto, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639692/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
8

Detection of human epidermal growth factor receptor 2 overe..:

YOSHIMOTO, Sho ; KATO, Daiki ; KAMOTO, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656818/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
9

Supplementary Figure Legends from Podoplanin Drives Amoeboi..:

Masahiro Shinada ; Daiki Kato ; Tomoki Motegi...
doi:10.1158/1541-7786.24474227.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
10

Supplementary Figure 10 from Podoplanin Drives Amoeboid Inv..:

Masahiro Shinada ; Daiki Kato ; Tomoki Motegi...
doi:10.1158/1541-7786.24474266.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
11

Supplementary Figure 7 from Podoplanin Drives Amoeboid Inva..:

Masahiro Shinada ; Daiki Kato ; Tomoki Motegi...
doi:10.1158/1541-7786.24474236.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
12

Supplementary Figure 4 from Podoplanin Drives Amoeboid Inva..:

Masahiro Shinada ; Daiki Kato ; Tomoki Motegi...
doi:10.1158/1541-7786.24474248.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
13

Supplementary Figure 2 from Podoplanin Drives Amoeboid Inva..:

Masahiro Shinada ; Daiki Kato ; Tomoki Motegi...
doi:10.1158/1541-7786.24474254.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
14

Supplementary Figure 5 from Podoplanin Drives Amoeboid Inva..:

Masahiro Shinada ; Daiki Kato ; Tomoki Motegi...
doi:10.1158/1541-7786.24474245.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
15

Supplementary Figure 8 from Podoplanin Drives Amoeboid Inva..:

Masahiro Shinada ; Daiki Kato ; Tomoki Motegi...
doi:10.1158/1541-7786.24474233.v1.  , 2023
Link: https://doi.org/10.1158/..
 
1-15